|
|
||||||||
Articles |
Pre-B-cell colony enhancing factor (PBEF) was first isolated from an activated peripheral blood lymphocyte cDNA library and was found to be involved in the maturation of B-cell precursors. It was subsequently identified as one of the genes upregulated by distending the human fetal membranes in vitro. Here we report on the genomic organization of this gene, which is composed of 11 exons and 10 introns, spanning 34.7 kb of genomic DNA. Neither the gene nor the protein has any homology with other cytokines in any currently available database. The use of two promoters (proximal and distal) may result in differential, tissue specific expression of the PBEF transcripts. The 5'-flanking region lacks the classical sequence motif that would place it with the hematopoietic cytokines; however, it has several putative regulatory elements, suggesting that this gene may be chemically and mechanically responsive to inducers of transcription. The three PBEF mRNA transcripts were observed in both normal and infected human fetal membranes but were significantly upregulated (P<0.05) in severe infection. The PBEF protein was immunolocalized, in both normal and infected tissues, to both the normal fetal cells of the amnion and chorion and the maternal decidua of the membranes, and to the invading neutrophils. These stained strongly and were likely to contribute to the increased expression in infection. The amniotic epithelial cell line (WISH cells) has been used as a model to study PBEF gene modulation. Lipopolysaccharide, interleukin (IL)-1beta, tumour necrosis factor (TNF)alpha and IL-6 all significantly increased the expression of PBEF in 4 h of treatment. The addition of dexamethasone to IL-1beta and TNFalpha significantly reduced the response of PBEF to these cytokines. IL-8 treatment failed to alter PBEF gene expression. Thus PBEF is a cytokine expressed in the normal fetal membranes and upregulated when they are infected. It is likely to have a central role in the mechanism of infection-induced preterm birth.
This article has been cited by other articles:
![]() |
R. Kamp, X. Sun, and J. G. N. Garcia Making Genomics Functional: Deciphering the Genetics of Acute Lung Injury Proceedings of the ATS, April 15, 2008; 5(3): 348 - 353. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Luk, Z. Malam, and J. C. Marshall Pre-B cell colony-enhancing factor (PBEF)/visfatin: a novel mediator of innate immunity J. Leukoc. Biol., April 1, 2008; 83(4): 804 - 816. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Malamitsi-Puchner, D. D. Briana, M. Boutsikou, E. Kouskouni, D. Hassiakos, and D. Gourgiotis Perinatal Circulating Visfatin Levels in Intrauterine Growth Restriction Pediatrics, June 1, 2007; 119(6): e1314 - e1318. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. J. Meyer and J. G. N. Garcia Wading into the Genomic Pool to Unravel Acute Lung Injury Genetics Proceedings of the ATS, January 1, 2007; 4(1): 69 - 76. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. A. Simon, R. B. Easley, D. N. Grigoryev, S.-F. Ma, S. Q. Ye, T. Lavoie, R. M. Tuder, and J. G. N. Garcia Microarray analysis of regional cellular responses to local mechanical stress in acute lung injury Am J Physiol Lung Cell Mol Physiol, November 1, 2006; 291(5): L851 - L861. [Abstract] [Full Text] [PDF] |
||||
![]() |
T.-F. Chan, Y.-L. Chen, C.-H. Lee, F.-H. Chou, L.-C. Wu, S.-B. Jong, and E.-M. Tsai Decreased Plsma Visfatin Concentrations in Women With Gestational Diabetes Mellitus Reproductive Sciences, July 1, 2006; 13(5): 364 - 367. [Abstract] [PDF] |
||||
![]() |
Y. Bottcher, D. Teupser, B. Enigk, J. Berndt, N. Kloting, M. R. Schon, J. Thiery, M. Bluher, M. Stumvoll, and P. Kovacs Genetic Variation in the Visfatin Gene (PBEF1) and Its Relation to Glucose Metabolism and Fat-Depot-Specific Messenger Ribonucleic Acid Expression in Humans J. Clin. Endocrinol. Metab., July 1, 2006; 91(7): 2725 - 2731. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Hammarstedt, J. Pihlajamaki, V. Rotter Sopasakis, S. Gogg, P.-A. Jansson, M. Laakso, and U. Smith Visfatin Is an Adipokine, But It Is Not Regulated by Thiazolidinediones J. Clin. Endocrinol. Metab., March 1, 2006; 91(3): 1181 - 1184. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. A. Nonas, J. H. Finigan, L. Gao, and J. G. N. Garcia Functional Genomic Insights into Acute Lung Injury: Role of Ventilators and Mechanical Stress Proceedings of the ATS, October 1, 2005; 2(3): 188 - 194. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Kralisch, J. Klein, U. Lossner, M. Bluher, R. Paschke, M. Stumvoll, and M. Fasshauer Interleukin-6 is a negative regulator of visfatin gene expression in 3T3-L1 adipocytes Am J Physiol Endocrinol Metab, October 1, 2005; 289(4): E586 - E590. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. L. Archer Pre-B-cell Colony-Enhancing Factor Regulates Vascular Smooth Muscle Maturation Through a NAD+-Dependent Mechanism: Recognition of a New Mechanism for Cell Diversity and Redox Regulation of Vascular Tone and Remodeling Circ. Res., July 8, 2005; 97(1): 4 - 7. [Full Text] [PDF] |
||||
![]() |
S. Q. Ye, B. A. Simon, J. P. Maloney, A. Zambelli-Weiner, L. Gao, A. Grant, R. B. Easley, B. J. McVerry, R. M. Tuder, T. Standiford, et al. Pre-B-Cell Colony-enhancing Factor as a Potential Novel Biomarker in Acute Lung Injury Am. J. Respir. Crit. Care Med., February 15, 2005; 171(4): 361 - 370. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Fukuhara, M. Matsuda, M. Nishizawa, K. Segawa, M. Tanaka, K. Kishimoto, Y. Matsuki, M. Murakami, T. Ichisaka, H. Murakami, et al. Visfatin: A Protein Secreted by Visceral Fat That Mimics the Effects of Insulin Science, January 21, 2005; 307(5708): 426 - 430. [Abstract] [Full Text] [PDF] |
||||
![]() |
K.W. Marvin, J.A. Keelan, R.L. Eykholt, T.A. Sato, and M.D. Mitchell Use of cDNA arrays to generate differential expression profiles for inflammatory genes in human gestational membranes delivered at term and preterm Mol. Hum. Reprod., April 1, 2002; 8(4): 399 - 408. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |